Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5521)
DBV Technologies S.A. (DBVT)
Mohideen Pharis — Chief Medical Officer
Shares
534
Price
$4.86
Total Value
$2.60K
Shares Held After
144,995
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
63
Price
$103.39
Total Value
$6.51K
Shares Held After
58,117
% of Holdings
0.1%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,819
Price
$102.67
Total Value
$186.76K
Shares Held After
58,180
% of Holdings
3.0%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
3,429
Price
$101.80
Total Value
$349.07K
Shares Held After
59,999
% of Holdings
5.4%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
189
Price
$100.95
Total Value
$19.08K
Shares Held After
63,428
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
8,667
Price
$29.74
Total Value
$257.78K
Shares Held After
986,667
% of Holdings
0.9%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
16,333
Price
$29.19
Total Value
$476.80K
Shares Held After
995,334
% of Holdings
1.6%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
6,772
Price
$40.12
Total Value
$271.69K
Shares Held After
38,673
% of Holdings
14.9%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
2,800
Price
$45.01
Total Value
$126.02K
Shares Held After
10,503
% of Holdings
21.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,500
Price
$44.04
Total Value
$154.15K
Shares Held After
13,303
% of Holdings
20.8%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
1,200
Price
$43.18
Total Value
$51.82K
Shares Held After
16,803
% of Holdings
6.7%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
21,262
Price
$18.55
Total Value
$394.41K
Shares Held After
371,885
% of Holdings
5.4%
INTUITIVE SURGICAL INC (ISRG)
Curet Myriam — EVP & Chief Medical Officer
Shares
126
Price
$520.02
Total Value
$65.52K
Shares Held After
0
% of Holdings
100.0%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
876
Price
$230.92
Total Value
$202.29K
Shares Held After
59,059
% of Holdings
1.5%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
991
Price
$229.94
Total Value
$227.87K
Shares Held After
59,935
% of Holdings
1.6%
ELUTIA INC. (ELUT)
NEELS GUIDO J — Director
Shares
15,000
Price
$1.06
Total Value
$15.90K
Shares Held After
98,750
% of Holdings
15.2%
IRIDEX CORP (IRIX)
Dizon Romeo R — Chief Financial Officer
Shares
1,101
Price
$1.44
Total Value
$1.59K
Shares Held After
112,690
% of Holdings
1.0%
InspireMD, Inc. (NSPR)
Gleason Shane Thomas — Chief Commercial Officer
Shares
12,395
Price
$1.65
Total Value
$20.46K
Shares Held After
1,149,077
% of Holdings
1.1%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
664
Price
$19.05
Total Value
$12.65K
Shares Held After
393,147
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
5,860
Price
$18.61
Total Value
$109.05K
Shares Held After
393,811
% of Holdings
1.5%
MASIMO CORP (MASI)
Sampath Anand — EVP, Ops & Clinical Research
Shares
196
Price
$138.09
Total Value
$27.07K
Shares Held After
40,909
% of Holdings
0.5%
MASIMO CORP (MASI)
Sampath Anand — EVP, Ops & Clinical Research
Shares
6,560
Price
$137.22
Total Value
$900.16K
Shares Held After
41,105
% of Holdings
13.8%
MASIMO CORP (MASI)
Sampath Anand — EVP, Ops & Clinical Research
Shares
11,924
Price
$136.56
Total Value
$1.63M
Shares Held After
47,665
% of Holdings
20.0%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
811
Price
$14.48
Total Value
$11.75K
Shares Held After
0
% of Holdings
100.0%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
2,800
Price
$14.09
Total Value
$39.44K
Shares Held After
811
% of Holdings
77.5%
Solid Biosciences Inc. (SLDB)
Ganot Ilan — Director
Shares
191
Price
$6.59
Total Value
$1.26K
Shares Held After
17,476
% of Holdings
1.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
30,526
Price
$66.06
Total Value
$2.02M
Shares Held After
16,055,469
% of Holdings
0.2%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
102,474
Price
$65.41
Total Value
$6.70M
Shares Held After
16,085,995
% of Holdings
0.6%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
7,619
Price
$66.06
Total Value
$503.31K
Shares Held After
8,941,533
% of Holdings
0.1%
Tempus AI, Inc. (TEM)
LEFKOFSKY ERIC P — Director
Shares
25,631
Price
$65.41
Total Value
$1.68M
Shares Held After
8,949,152
% of Holdings
0.3%
Natera, Inc. (NTRA)
Chapman Steven Leonard — Director
Shares
3,648
Price
$237.66
Total Value
$866.99K
Shares Held After
213,180
% of Holdings
1.7%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
1,176
Price
$237.44
Total Value
$279.23K
Shares Held After
60,926
% of Holdings
1.9%
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
1,237
Price
$237.66
Total Value
$293.99K
Shares Held After
62,102
% of Holdings
2.0%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,200
Price
$237.66
Total Value
$285.19K
Shares Held After
142,486
% of Holdings
0.8%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
928
Price
$237.66
Total Value
$220.55K
Shares Held After
175,540
% of Holdings
0.5%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
191
Price
$237.66
Total Value
$45.39K
Shares Held After
263,596
% of Holdings
0.1%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
1,000
Price
$237.66
Total Value
$237.66K
Shares Held After
225,147
% of Holdings
0.4%
Ainos, Inc. (AIMD)
Taiwan Carbon Nano Technology Corp — 10% Owner
Shares
46,000
Price
$2.17
Total Value
$99.81K
Shares Held After
989,925
% of Holdings
4.4%
ELUTIA INC. (ELUT)
NEELS GUIDO J — Director
Shares
15,000
Price
$1.06
Total Value
$15.90K
Shares Held After
83,750
% of Holdings
17.9%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
50
Price
$7.03
Total Value
$351.50
Shares Held After
22,622
% of Holdings
0.2%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
4,968
Price
$140.24
Total Value
$696.73K
Shares Held After
556,698
% of Holdings
0.9%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
5,032
Price
$139.54
Total Value
$702.19K
Shares Held After
561,666
% of Holdings
0.9%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
32,612
Price
$31.80
Total Value
$1.04M
Shares Held After
24,353
% of Holdings
57.2%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
1,695
Price
$8.45
Total Value
$14.32K
Shares Held After
249,301
% of Holdings
0.7%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
2,686
Price
$8.45
Total Value
$22.70K
Shares Held After
420,047
% of Holdings
0.6%
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
1,354
Price
$8.45
Total Value
$11.44K
Shares Held After
276,610
% of Holdings
0.5%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
6,500
Price
$3.57
Total Value
$23.19K
Shares Held After
0
% of Holdings
100.0%
Anixa Biosciences, Inc. (ANIX)
Baskies Arnold M — Director
Shares
10,000
Price
$3.04
Total Value
$30.40K
Shares Held After
135,000
% of Holdings
7.4%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
2,671
Price
$3.00
Total Value
$8.02K
Shares Held After
173,999
% of Holdings
1.5%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
8,717
Price
$4.91
Total Value
$42.80K
Shares Held After
580,329
% of Holdings
1.5%
Showing 3451–3500 of 5521 transactions (page 70 of 111)